Literature DB >> 9575844

Regulation of intestinal Cl- and HCO3-secretion by uroguanylin.

N S Joo1, R M London, H D Kim, L R Forte, L L Clarke.   

Abstract

Uroguanylin is an intestinal peptide hormone that may regulate epithelial ion transport by activating a receptor guanylyl cyclase on the luminal surface of the intestine. In this study, we examined the action of uroguanylin on anion transport in different segments of freshly excised mouse intestine, using voltage-clamped Ussing chambers. Uroguanylin induced larger increases in short-circuit current (Isc) in proximal duodenum and cecum compared with jejunum, ileum, and distal colon. The acidification of the lumen of the proximal duodenum (pH 5.0-5.5) enhanced the stimulatory action of uroguanylin. In physiological Ringer solution, a significant fraction of the Isc stimulated by uroguanylin was insensitive to bumetanide and dependent on HCO3- in the bathing medium. Experiments using pH-stat titration revealed that uroguanylin stimulates serosal-to-luminal HCO3- secretion (Js-->lHCO3-) together with a larger increase in Isc. Both Js-->lHCO3- and Isc were significantly augmented when luminal pH was reduced to pH 5.15. Uroguanylin also stimulated the Js-->lHCO3- and Isc across the cecum, but luminal acidity caused a generalized decrease in the bioelectric responsiveness to agonist stimulation. In cystic fibrosis transmembrane conductance regulator (CFTR) knockout mice, the duodenal Isc response to uroguanylin was markedly reduced, but not eliminated, despite having a similar density of functional receptors. It was concluded that uroguanylin is most effective in acidic regions of the small intestine, where it stimulates both HCO3- and Cl-secretion primarily via a CFTR-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575844     DOI: 10.1152/ajpgi.1998.274.4.G633

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

Review 1.  New treatment options for chronic constipation: mechanisms, efficacy and safety.

Authors:  Michael Camilleri
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

2.  Guanylin and functional coupling proteins in the hepatobiliary system of rat and guinea pig.

Authors:  Karen Schwabe; Yalcin Cetin
Journal:  Histochem Cell Biol       Date:  2012-02-07       Impact factor: 4.304

Review 3.  A guide to Ussing chamber studies of mouse intestine.

Authors:  Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

4.  Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.

Authors:  Marta Zielińska; Agata Jarmuż; Andrzej Wasilewski; Gerta Cami-Kobeci; Stephen Husbands; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2016-12-05       Impact factor: 3.024

Review 5.  Linaclotide - a secretagogue and antihyperalgesic agent - what next?

Authors:  A E Bharucha; D R Linden
Journal:  Neurogastroenterol Motil       Date:  2010-03       Impact factor: 3.598

6.  Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat.

Authors:  Nicholas G Moss; Dorothy A Riguera; Robert C Fellner; Christopher Cazzolla; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

7.  Guanylin and functional coupling proteins in the human salivary glands and gland tumors : expression, cellular localization, and target membrane domains.

Authors:  Hasan Kulaksiz; Elisabeth Rehberg; Wolfgang Stremmel; Yalcin Cetin
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

Review 9.  The use of oral rehydration solutions in children and adults.

Authors:  Timothy A Sentongo
Journal:  Curr Gastroenterol Rep       Date:  2004-08

10.  The natriuretic peptide uroguanylin elicits physiologic actions through 2 distinct topoisomers.

Authors:  Nicholas G Moss; Dorothy A Riguera; Robert M Solinga; Marco M Kessler; Daniel P Zimmer; William J Arendshorst; Mark G Currie; Michael F Goy
Journal:  Hypertension       Date:  2009-03-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.